GlaxoSmithKline (GSK)

Type
Business expansion
Country
France
Region
Hauts-de-France; Nord-Pas de Calais; Nord
Location of affected unit(s)
Saint-Amand-les-Eaux
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.10 - Manufacture of basic pharmaceutical products
100 jobs
Number of planned job creations
Job creation
Announcement Date
2 April 2015
Employment effect (start)
1 May 2015
Foreseen end date
31 May 2018

Description

Pharmaceutical products manufacturer GlaxoSmithKline (GSK) has announced to recruit about 100 employees between now and 2018 at its Saint-Amand-les-Eaux site which currently employs 680 people. The group want to invest 6 million to produce a malaria vaccine. The company's vaccines production platform has received EUR 600mn in investments since 2006.

Sources

  • 2 April 2015: L'usine Nouvelle

Citation

Eurofound (2015), GlaxoSmithKline (GSK), Business expansion in France, factsheet number 83611, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/83611.